MYH11延长突变导致巨膀胱-小结肠-肠蠕动不良综合征1例报告及文献复习

doi:10.12372/jcp.2024.24e0263

Abstract

Abstract:

Objective To report the clinical characteristics and genetic variant of a patient with megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) and to investigate the genotypic-phenotypic correlation through literatures review. Methods The clinical data of a MMIHS child who came to our hospital in October 2023 due to "repeated abdominal distension and vomiting for more than 3 years" were analyzed. Peripheral blood samples were collected from the patient, his parents and his older sister, and the pathogenic mutation was screened by Trio-WES and Sanger sequencing. Relevant literature was summarized and analyzed. Results The patient, a 15-year-old boy, presented with recurrent episodes of abdominal distension, vomiting, and abdominal pain. Abdominal X-ray and upper gastrointestinal contrast study indicated intestinal obstruction. The condition stabilized after treatment with enema, anti-infection and intravenous nutritional support. Genetic testing revealed a heterozygous mutation in the MYH11 gene, identified as c.5819delC (p.Pro1940Hisfs*91), which resulted in the extension of the C-end of the myosin heavy chain and was not detected by either parent or sister. A total of 7 articles related to MYH11 gene mutation were included in the literature review. Mutation types included missense mutations, frameshift mutations, and chromosomal microdeletion. Gender was undetermined in 2 out of 20 patients due to early termination of pregnancy. Among the remaining patients, the male-to-female ratio was 2:1. Genotypic-phenotypic correlation analysis found that 15 patients with dominant heterozygous protein‐elongating MYH11 variants were aged 9 (0-28) years at onset, and no deaths were reported. Five patients with recessive loss-of-function mutations had an onset age of less than 1 year, with 4 deaths (80%). Conclusion This MMIHS patient carries the MYH11 gene c.5819delC (p. Pro1940Hisfs*91) mutation. Compared with patients with MYH11 gene mutation recessive inheritance, those with dominant MYH11 mutations tend to have a later onset, milder clinical manifestations, and a higher survival rate.

Key words: megacystis-microcolon-intestinal hypoperistalsis syndrome, MYH11 gene, child

ZHOU Jie, LIU Keqiang, WANG Jinling, WANG Ying. Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review[J].Journal of Clinical Pediatrics, 2024, 42(9): 798-804.

Figures/Tables 6

References 29

[1]	Hashmi SK, Ceron RH, Heuckeroth RO. Visceral myopathy: clinical syndromes, genetics, pathophysiology, and fall of the cytoskeleton[J]. Am J Physiol Gastrointest Liver Physiol, 2021, 320(6): G919-G935.
[2]	Fournier N, Fabre A. Smooth muscle motility disorder phenotypes: a systematic review of cases associated with seven pathogenic genes (ACTG2, MYH11, FLNA, MYLK, RAD21, MYL9 and LMOD1)[J]. Intractable Rare Dis Res, 2022, 11(3): 113-119.
[3]	Halim D, Wilson MP, Oliver D, et al. Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice[J]. Proc Natl Acad Sci U S A, 2017, 114(13): E2739-E2747.
[4]	Halim D, Brosens E, Muller F, et al. Loss-of-function variants in MYLK cause recessive megacystis microcolon intestinal hypoperistalsis syndrome[J]. Am J Hum Genet, 2017, 101(1): 123-129. doi: S0002-9297(17)30198-2 pmid: 28602422
[5]	Moreno CA, Sobreira N, Pugh E, et al. Homozygous deletion in MYL9 expands the molecular basis of megacystis-microcolon-intestinal hypoperistalsis syndrome[J]. Europ J Hum Genet, 2018, 26(5): 669-675.
[6]	Li N, Song YM, Zhang XD, et al. Pseudoileus caused by primary visceral myopathy in a Han Chinese patient with a rare MYH11 mutation: a case report[J]. World J Clin Cases, 2022, 10(34): 12623-12630.
[7]	Frismantiene A, Philippova M, Erne P, et al. Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity[J]. Cell Signal, 2018, 52: 48-64. doi: S0898-6568(18)30203-1 pmid: 30172025
[8]	Babu GJ, Warshaw DM, Periasamy M. Smooth muscle myosin heavy chain isoforms and their role in muscle physiology[J]. Microsc Res Tech, 2000, 50(6): 532-540.
[9]	Li M, Li S, Rao Y et al. Loss of smooth muscle myosin heavy chain results in the bladder and stomach developing lesion during foetal development in mice[J]. J Genet, 2018, 97(2): 469-475. pmid: 29932067
[10]	Milewicz DM, Trybus KM, Guo DC, et al. Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections[J]. Arterioscler Thromb Vasc Biol, 2017, 37(1): 26-34. doi: 10.1161/ATVBAHA.116.303229 pmid: 27879251
[11]	Gilbert MA, Schultz-Rogers L, Rajagopalan R, et al. Protein-elongating mutations in MYH11 are implicated in a dominantly inherited smooth muscle dysmotility syndrome with severe esophageal, gastric, and intestinal disease[J]. Hum Mutat, 2020, 41(5): 973-982.
[12]	Dong W, Baldwin C, Choi J, et al. Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction: Results of whole-exome sequencing[J]. Clin Genet, 2019, 96(5): 473-477.
[13]	Wang Q, Zhang J, Wang H, et al. Compound heterozygous variants in MYH11 underlie autosomal recessive megacystis-microcolon-intestinal hypoperistalsis syndrome in a Chinese family[J]. J Hum Genet, 2019, 64(11): 1067-1073. doi: 10.1038/s10038-019-0651-z pmid: 31427716
[14]	Kloth K, Renner S, Burmester G, et al. 16p13.11 microdeletion uncovers loss-of-function of a MYH11 missense variant in a patient with megacystis-microcolon-intestinal-hypoperistalsis syndrome[J]. Clin Genet, 2019, 96(1): 85-90. doi: 10.1111/cge.13557 pmid: 31044419
[15]	Yetman AT, Starr LJ. Newly described recessive MYH11 disorder with clinical overlap of multisystemic smooth muscle dysfunction and megacystis microcolon hypoperistalsis syndromes[J]. Am J Med Genet A, 2018, 176(4): 1011-1014. doi: 10.1002/ajmg.a.38647 pmid: 29575632
[16]	Gauthier J, Ouled Amar Bencheikh B, Hamdan FF, et al. A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome[J]. Europ J Hum Genet, 2015, 23(9): 1266-1268.
[17]	Thapar N, Saliakellis E, Benninga MA, et al. Paediatric intestinal pseudo-obstruction: evidence and consensus-based recommendations from an ESPGHAN-led expert group[J]. J Pediatr Gastroenterol Nutr, 2018, 66(6): 991-1019.
[18]	Fontanella F, Maggio L, Verheij JBGM, et al. Fetal megacystis: a lot more than LUTO[J]. Ultrasound Obstet Gynecol, 2019, 53(6): 779-787. doi: 10.1002/uog.19182 pmid: 30043466
[19]	Geraghty RM, Orr S, Olinger E, et al. Use of whole genome sequencing to determine the genetic basis of visceral myopathies including Prune Belly syndrome[J]. J Rare Dis (Berlin), 2023, 2(1): 9. doi: 10.1007/s44162-023-00012-z pmid: 37288276
[20]	Buinoiu N, Panaitescu A, Demetrian M, et al. Ultrasound prenatal diagnosis of typical megacystis, microcolon, intestinal hypoperistalsis syndrome[J]. Clin Case Rep, 2018, 6(5): 855-858.
[21]	Rosenblatt J, Dreux S, Spaggiari E, et al. Prenatal diagnosis of megacystis microcolon intestinal hypoperistalsis syndrome by biochemical analysis of fetal urine[J]. Prenatal Diagn, 2018. doi: 10.1002/pd.5283.
[22]	Di Nardo G, Zenzeri L, Guarino M, et al. Pharmacological and nutritional therapy of children and adults with chronic intestinal pseudo-obstruction[J]. Expert Rev Gastroenterol Hepatol, 2023, 17(4): 325-341.
[23]	Viti F, De Giorgio R, Ceccherini I, et al. Multi-disciplinary Insights from the first European forum on visceral myopathy 2022 meeting[J]. Dig Dis Sci, 2023, 68(10): 3857-3871.
[24]	Kim SJ, Lee S, Park HJ, et al. Genetic association of MYH genes with hereditary hearing loss in Korea[J]. Gene, 2016, 591(1): 177-182.
[25]	Kocoshis SA, Goldschmidt ML, Nathan JD, et al. Esophageal dysmotility: an intrinsic feature of megacystis, microcolon, hypoperistalsis syndrome (MMIHS)[J]. J Pediatr Surg, 2019, 54(7): 1303-1307. doi: S0022-3468(18)30558-X pmid: 30257810
[26]	Kapur RP. Histopathological, ultrastructural, and immunohistochemical findings in MYH11-variant visceral myopathy[J]. Pediatr Dev Pathol, 2023, 26(1): 39-51.
[27]	Zhu L, Vranckx R, Khau Van Kien P, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus[J]. Nat Genet, 2006, 38(3): 343-349. doi: 10.1038/ng1721 pmid: 16444274
[28]	Chi M, Zhou Y, Vedamoorthyrao S, et al. Ablation of smooth muscle myosin heavy chain SM2 increases smooth muscle contraction and results in postnatal death in mice[J]. Proc Natl Acad Sci U S A, 2008, 105(47): 18614-18618.
[29]	Kuang SQ, Kwartler CS, Byanova KL, et al. Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells[J]. Circul Res, 2012, 110(11): 1411-1422.

病例	性别	发病年龄	消化系统症状	泌尿系统症状	其他	结局	文献
1	男	0	小结肠、便秘	巨膀胱、尿潴留	羊水少	死亡	[16]
2	男	0	小结肠	巨膀胱、肾盂扩张、输尿管扩张	瞳孔扩大、羊水少、感音神经性听力损失、肺动脉高压、主动脉扩张	死亡	[15]
3-1	－	0	－	巨膀胱	羊水少	终止妊娠	[13]
3-2	－	0	－	巨膀胱	羊水少	终止妊娠	[13]
4	女	0	小结肠	巨膀胱	生长激素缺乏、甲状腺功能减退、瞳孔扩大	存活	[14]
5	女	0	假性肠梗阻、回肠扭转、肛门括约肌张力低下	－	－	存活	[11]
6-1	男	11岁	食管裂孔疝	－	－	存活	[11]
6-2	男	7岁	食管裂孔疝、食道狭窄	－	－	存活
6-3	男	12岁	食管裂孔疝、食道狭窄	－	－	存活
6-4	女	4岁	食管裂孔疝、结肠动力障碍、十二指肠扩张	－	－	存活
6-5	女	4岁	食管裂孔疝、食道狭窄、十二指肠、空肠动力异常、坏死性小肠结肠炎	－	－	存活
7	男	12岁	假性肠梗阻	肾积水、尿路感染	－	存活	本文

病例	DNA	蛋白	突变类型	遗传方式	文献
1	c.3598A>T	p.Lys1200Ter	纯合错义突变	AR	[16]
2	c.2809_2810del；c.3422_3470del	p.Arg937Glyfs7；p.Lys1141Thrfs20	复合杂合突变	AR	[15]
3	c.2051G>A；c.3540_3541delinsTT	p.R684H ；p.（E1180D, Q1181Ter）	复合杂合突变	AR	[13]
4	c.379C>T；16p13.11 中1.3 Mb微缺失	p.Pro127Ser	复合杂合突变	AR	[14]
5	c.5819delC	p.Pro1940Hisfs*91	杂合延长突变	AD	[11]
6	c.5819_5820insCA	p.Gln1941Asnfs*91	杂合延长突变	AD	[11]
7	c.5819delC	p.Pro1940Hisfs*91	杂合延长突变	AD	本文
8	c.5819delC	p.Pro1940HisfsTer91	杂合延长突变	AD	[12]
9	c.5819delC	p.Pro1940Hisfs*91	杂合延长突变	AD	[6]

Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 6

References 29

Related Articles 15

Metrics

Comments

Recommended 0

[1]	QIU Xiu, WEI Dongmei, LIN Shanshan, XIA Huimin, ZHOU Wenhao. Principles and practice of the Born in Guangzhou Cohort Study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 747-752.
[2]	FAN Jianxia. The origins and development of the healthy life trajectory program: a cohort of community-family-mother-child multidimensional interventions for overweight and obesity in children [J]. Journal of Clinical Pediatrics, 2024, 42(9): 768-773.
[3]	JIANG Tao, LI Shuangjie, TANG Lian, OUYANG Wenxian. Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B [J]. Journal of Clinical Pediatrics, 2024, 42(9): 787-790.
[4]	CHU Sijia, TANG Jihong. Research progress of central nervous system injury associated with pediatric acute lymphoblastic leukemia and its treatment [J]. Journal of Clinical Pediatrics, 2024, 42(9): 811-816.
[5]	DING Yaping, XIA Shanshan, ZHANG Chenmei. Interpretation of “2023 Children’s Renal Nutrition Working Group Clinical Practice Recommendations: Nutritional Management of Children with Acute Kidney Injury” [J]. Journal of Clinical Pediatrics, 2024, 42(8): 667-672.
[6]	LI Yirong, LI Huiping, GAO Jingyu, XIAO Yuhua, CHEN Xiaomin, LU Yanling, ZHAO Nana, FENG Xiaoqin. Comparison of different doses of cytarabine for induction chemotherapy in children with acute myeloid leukemia in FLAG-IDA regimen [J]. Journal of Clinical Pediatrics, 2024, 42(8): 673-677.
[7]	HUANG Bo, DONG Yanying, SONG Linlan. Clinical characteristics of 348 children with infectious mononucleosis [J]. Journal of Clinical Pediatrics, 2024, 42(8): 678-683.
[8]	WANG Dan, SHAO Jingbo, LI Hong, ZHANG Na, ZHU Jiashi, FU Pan, WANG Zhen. Clinical analysis of 38 cases of hematological malignancies complicated with tumor lysis syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 684-690.
[9]	MA Yan, WEI Xingjiao, BAI Hua, ZHANG Yan, TIAN Xinmin, Aqsa Ahmad, LIANG Lijun. Analysis of etiological composition and clinical features of stage 5 chronic kidney disease in children in a tertiary hospital in western China [J]. Journal of Clinical Pediatrics, 2024, 42(8): 697-703.
[10]	WANG Ye, ZHANG Linlin, CHI Zuofei, SUN Ruowen, JIANG Zehui, XU Gang. A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 722-727.
[11]	HUANG Shiyu, WANG Wei, ZHU Diqi, SHEN Jie, CAO Qing. Treatment and reflection of infective endocarditis caused by methicillin-resistant Staphylococcus aureus in children after complex congenital heart disease [J]. Journal of Clinical Pediatrics, 2024, 42(8): 728-736.
[12]	CHAI Yahui, YANG Dasheng, ZHANG He, BI Lingyun. Progress of Clinical Research on IgA Vasculitis in Children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 737-740.
[13]	DENG Menglu, ZHANG Jie, SHENG Wenbin. Research progress of gut microbiota in allergic diseases in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 741-746.
[14]	LI Benshang, YANG Liu. Challenges and prospects of CAR-T treatment for pediatric disease [J]. Journal of Clinical Pediatrics, 2024, 42(7): 573-577.
[15]	LU Jun. The clinical significance and management strategies of B cell aplasia following CD19 CAR-T cell therapy in pediatric patients [J]. Journal of Clinical Pediatrics, 2024, 42(7): 578-582.